We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.

We offer clients exceptional insight in dealing with competition agencies in the United States, Europe and around the world.

“The firm is at its best during a fight—whether that’s against an enforcer, or in court against a private litigant.” — Global Competition Review

Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

WilmerHale’s lawyers are renowned for their work on mergers and acquisitions, IPOs, private equity deals, strategic alliances and corporate governance matters both domestically and in the EU and China. Healthcare clients, which include Medtronic and PerkinElmer, know us as a one-stop source for solutions to the diverse array of corporate issues they face.

For clients that range from public and private companies to individual entrepreneurs, our corporate lawyers have:

• Served as issuer counsel or underwriters’ counsel in more than 400 public offerings and Rule 144A placements raising nearly $150 billion since 2006. We have a wide array of capital markets experience, as well as significant commercial finance knowledge.
• Advised on more than 1,000 M&A deals with a total value in excess of $400 billion since 2006. Our experience ranges from public-public mergers and related SEC, disclosure and fiduciary duty issues to the unique issues presented by sales of private equity and venture-backed private companies.
• Handled hundreds of strategic alliances, joint ventures, outsourcing and licensing transactions each year, including several strategic alliances that have received industry recognition for their importance. The complexity of these deals often demands deep experience and close collaboration among our corporate, licensing, intellectual property and tax lawyers, as well as our lawyers in the United States, Europe and Asia.

For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their businesses possible, including a broad range of licensing, collaboration, strategic alliance and joint venture agreements. Our attorneys also excel at brokering manufacturing and supply agreements, contract research and development agreements, distribution and commercialization services agreements, and material transfer and confidentiality agreements. They also frequently represent life sciences clients as they license patents—often the foundations of their companies—from, and sponsor research at, leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances, and successfully navigate a complex, dynamic industry.

WilmerHale has one of the leading antitrust and competition practices in the United States and Europe, as consistently recognized by publications such as Chambers and Global Competition Review. With more than 70 competition lawyers in the United States, Europe and China, we can advise healthcare providers and payers on the full spectrum of antitrust issues in the jurisdictions where they do business. We regularly counsel on the issues associated with a company’s operational activities, we have secured antitrust clearance for hundreds of complex mergers and joint ventures, and we have won numerous victories for clients in private and government litigation. Our deep knowledge of securing merger clearance should put us at the top of the list for any healthcare company facing acquisition decisions.

Some of our recent successes in the healthcare sector include representing a major insurance carrier in the Insurance Brokerage Antitrust Litigation, where we successfully secured dismissal of all federal antitrust, RICO and ERISA claims in the consolidated class action complaint against employee benefits insurers, as well as the related state law claims. We also recently represented the second-largest provider of regulated medical waste services in obtaining clearance for its acquisition by the largest provider of those services.

When legal, public policy and media challenges converge and an institution's reputation and business are at stake, no firm rivals WilmerHale’s ability to navigate fast-moving events and craft lasting solutions.

WilmerHale’s corporate lawyers have a long history of experience with cross-border deals involving mergers and acquisitions, public offerings and capital markets, venture capital, joint ventures and other transactions.